MYLK and neoplasm: Using the inhibitors wortmannin (PI3K inhibitor at 250 nM), Go6976 (PKCα inhibitor at 6 nM) and ML-7 (MLCK inhibitor at 10 μM), we were able to track down the key molecules of the signalling cascade of the glucose- and insulin-induced tumour cell migration.